Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort
Y Q Li(Princess Margaret Cancer Centre), Geoffrey Liu(Princess Margaret Cancer Centre), M. Chowdhury(Princess Margaret Cancer Centre), Khaleeq Khan(Princess Margaret Cancer Centre), Evan Strom(Princess Margaret Cancer Centre), Michael K. Wong(Princess Margaret Cancer Centre), James G. Herman(UPMC Hillman Cancer Center), P.A. Bradbury(Princess Margaret Cancer Centre), M. Catherine Brown(University Health Network), Adrian G. Sacher(Princess Margaret Cancer Centre), D. Patel(Princess Margaret Cancer Centre), David Shultz(University of Toronto), Lawson Eng(Princess Margaret Cancer Centre), Amir Sabouhanian(Princess Margaret Cancer Centre), L. Corke(Princess Margaret Cancer Centre), Luna Jia Zhan(University Health Network), F.A. Shepherd(Princess Margaret Cancer Centre), Sabine Schmid(University of Bern), K. Balatnaram(Princess Margaret Cancer Centre), Sierra Cheng(Princess Margaret Cancer Centre), Miguel García-Pardo(Hospital Universitario Ramón y Cajal), P. Walia(Princess Margaret Cancer Centre), Natasha B. Leighl(Princess Margaret Cancer Centre)
Cited by 4
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
|The Lancet|2014|1.8k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k